Table 3.
Age (yr) | Gender | AV (cm) | Grade | cN | Preoperative chemotherapy | ypT | Postoperative chemotherapy | Site of failure | DFS (mo) |
---|---|---|---|---|---|---|---|---|---|
53 | Male | 6 | Well | 0 | Capecitabine | 1 | 5-FU | Distant | 14 |
49 | Female | 1 | Well | 0 | Capecitabine | 0 | 5-FU | Locoregional | 14 |
41 | Female | 2 | Unknown | 1 | Capecitabine | 1 | 5-FU | Distant | 43 |
62 | Male | 2 | Moderate | 0 | 5-FU | 1 | No | Locoregional | 93 |
AV, anal verge; DFS, disease-free survival; 5-FU, 5-fluorouracil.